CME/CE

Episodes 511-525 of 957

• 

  MinuteCE®

  Index of Suspicion

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  0.50 credits 2 episodes

• 

  RestartResume

  Chemoradiotherapy Toxicities: How Do They Impact Starting Immunotherapy?

  MinuteCE®

  Chemoradiotherapy Toxicities: How Do They Impact Starting Immunotherapy?

  • 

    

    Joshua E. Reuss, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Resolving Practice Barriers to Consolidative Immunotherapy in Stage III NSCLC

  MinuteCE®

  Resolving Practice Barriers to Consolidative Immunotherapy in Stage III NSCLC

  • 

    

    Jhanelle E. Gray, MD

    Peer

  • 

    

    Joshua E. Reuss, MD

    Peer

  1.00 program credits

• 

  MinuteCE®

  Advances in Immunotherapy for Unresectable Stage III NSCLC   

  • 

    

    Joshua E. Reuss, MD

    Peer

  • 

    

    Jhanelle E. Gray, MD

    Peer

  1.00 credits 10 episodes

• 

  RestartResume

  Introduction to Right Heart Catheterization

  MinuteCE®

  Introduction to Right Heart Catheterization

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  0.50 program credits

• 

  RestartResume

  Accurate Staging and Determining Resectability in NSCLC

  MinuteCE®

  Accurate Staging and Determining Resectability in NSCLC

  • 

    

    Joshua E. Reuss, MD

    Peer

  1.00 program credits

• 

  RestartResume

  RHC Common Procedure

  MinuteCE®

  RHC Common Procedure

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Richard Krasuski, MD

    Peer

  1.75 program credits

• 

  RestartResume

  Evaluating The Wave Forms

  MinuteCE®

  Evaluating The Wave Forms

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Victor Moles, MD

    Peer

  1.75 program credits

• 

  RestartResume

  Calculating Cardiac Output

  MinuteCE®

  Calculating Cardiac Output

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Victor Moles, MD

    Peer

  1.75 program credits

• 

  MinuteCE®

  Things To Keep In Mind on The Day of The Procedure

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Victor Moles, MD

    Peer

  • 

    

    Richard Krasuski, MD

    Peer

  0.50 credits 2 episodes

• 

  RestartResume

  Unresectable Stage III NSCLC: Highlights From the Oncology Meeting in Chicago 2024

  MinuteCE®

  Unresectable Stage III NSCLC: Highlights From the Oncology Meeting in Chicago 2024

  • 

    

    Joshua E. Reuss, MD

    Peer

  • 

    

    Jhanelle E. Gray, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Optimizing Consolidative Immunotherapy in Unresectable Stage III NSCLC: Case Discussion

  MinuteCE®

  Optimizing Consolidative Immunotherapy in Unresectable Stage III NSCLC: Case Discussion

  • 

    

    Joshua E. Reuss, MD

    Peer

  • 

    

    Jhanelle E. Gray, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Consolidative Immunotherapy in Unresectable Stage III NSCLC With Oncogenic Drivers

  MinuteCE®

  Consolidative Immunotherapy in Unresectable Stage III NSCLC With Oncogenic Drivers

  • 

    

    Joshua E. Reuss, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Pre-Test Probability

  MinuteCE®

  Pre-Test Probability

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  0.50 program credits

• 

  RestartResume

  When To Use RHC For Follow-Up

  MinuteCE®

  When To Use RHC For Follow-Up

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Victor Moles, MD

    Peer

  1.25 program credits

• Prev
• 1
• 2
• …
• 33
• 34
• 35
• 36
• 37
• …
• 63
• 64
• Next